Resistance of Enterococci to Ampicillin and Glycopeptide Antibiotics in Italy | Zendy

Roberta Fontana | Zendy; Marco Ligozzi | Zendy; Annarita Mazzariol | Zendy; Gianluca Veneri | Zendy; Giuseppe Cornaglia | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Resistance of Enterococci to Ampicillin and Glycopeptide Antibiotics in Italy

Author(s) -

Roberta Fontana,

Marco Ligozzi,

Annarita Mazzariol,

Gianluca Veneri,

Giuseppe Cornaglia

Publication year - 1998

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/514907

Subject(s) - teicoplanin , enterococcus faecium , ampicillin , enterococcus faecalis , amp resistance , microbiology and biotechnology , vancomycin , medicine , enterococcus , glycopeptide , antibiotics , biology , bacteria , staphylococcus aureus , genetics

We report the results of the monitoring of resistance to ampicillin, vancomycin, and teicoplanin in enterococci by an Italian network of clinical microbiology laboratories. A total of 16,226 strains were analyzed; 9,169 of these strains were Enterococcus faecalis, 913 were Enterococcus faecium, and 6,144 were Enterococcus species. The average rate of resistance to ampicillin was 1.9% (range, 0-6.5%) for E. faecalis and 70% (range, 33.3%-98.7%) for E. faecium; the average rate of resistance to vancomycin was 1.1% (range, 0.1%-2%) for E. faecalis and 8.5% (range, 0-36.1%) for E. faecium; and the average rate of resistance to teicoplanin was 0.8% (range, 0-2.4%) for E. faecalis and 8.7% (range, 0-36.1%) for E. faecium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research